| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2019 ( Subtotal = -$456,114 ) |
| | 2019 | 2018 | L.E.A.F. THERAPEUTICS, LLC | 326 OVERLOOK LN | CONSHOHOCKEN | PA | 19428-2634 | MONTGOMERY | USA | R01AI116593 | The Role of IgE in Human Schistosomiasis | 000 | 5 | NIH | 2/7/2019 | $0 |
| | 2019 | 2018 | L.E.A.F. THERAPEUTICS, LLC | 326 OVERLOOK LN | CONSHOHOCKEN | PA | 19428-2634 | MONTGOMERY | USA | R01AI116593 | The Role of IgE in Human Schistosomiasis | 001 | 5 | NIH | 5/16/2019 | -$456,114 |
|
| Issue Date FY: 2018 ( Subtotal = $570,274 ) |
| | 2018 | 2018 | L.E.A.F. THERAPEUTICS, LLC | 326 OVERLOOK LN | CONSHOHOCKEN | PA | 19428-2634 | MONTGOMERY | USA | R01AI116593 | The Role of IgE in Human Schistosomiasis | 000 | 5 | NIH | 1/17/2018 | $570,274 |
|
| Issue Date FY: 2017 ( Subtotal = $417,515 ) |
| | 2017 | 2017 | L.E.A.F. THERAPEUTICS, LLC | 326 OVERLOOK LN | CONSHOHOCKEN | PA | 19428-2634 | MONTGOMERY | USA | R01AI116593 | The Role of IgE in Human Schistosomiasis | 002 | 4 | NIH | 7/14/2017 | $417,515 |
|
|
